A Randomized-Controlled Trial of Oral Low-Dose Isotretinoin for Difficult-To-Treat Papulopustular Rosacea
Open Access
- 5 February 2016
- journal article
- research article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 136 (6), 1124-1129
- https://doi.org/10.1016/j.jid.2016.01.025
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Rationale for unequal randomization in clinical trials is rarely reported: a systematic reviewJournal of Clinical Epidemiology, 2014
- The psychological impact of rosacea and the influence of current management optionsJournal of the American Academy of Dermatology, 2014
- Use of Thalidomide for Severe Recurrent Aphthous StomatitisMedicine, 2010
- Continuous 'microdose' isotretinoin in adult recalcitrant rosaceaClinical and Experimental Dermatology, 2004
- Efficacy of Low-Dose Isotretinoin in Patients With Treatment-Resistant RosaceaArchives of Dermatology, 1998
- Skindex, a Quality-of-Life Measure for Patients with Skin Disease: Reliability, Validity, and ResponsivenessJournal of Investigative Dermatology, 1996
- Treatment of Rosacea with IsotretinoinInternational Journal of Dermatology, 1986
- Response of rosacea to isotretinoinClinical and Experimental Dermatology, 1984
- Action of isotretinoin in acne rosacea and gram-negative folliculitisJournal of the American Academy of Dermatology, 1982
- A follow-up of tetracycline-treated rosacea.British Journal of Dermatology, 1975